Activation of the third complement component (C3) and C3a generation in cardiac anaphylaxis: histamine release and associated inotropic and chronotropic effects
- PMID: 2458450
Activation of the third complement component (C3) and C3a generation in cardiac anaphylaxis: histamine release and associated inotropic and chronotropic effects
Abstract
Activation of the complement system with generation of C3a and C5a anaphylatoxins occurs during immediate hypersensitivity reactions; furthermore, the administration of C3a and/or C5a into isolated hearts causes a dysfunction that closely resembles cardiac anaphylaxis. To determine whether complement is activated and anaphylatoxins are generated in the course of immediate hypersensitivity reactions of the heart, we have challenged presensitized isolated guinea pig atria and papillary muscles with the specific antigen in the presence of a source of complement. We have found that the anaphylactic reaction of these cardiac preparations is characterized by complement activation and C3a generation, as well as by histamine release and positive inotropic and chronotropic effects. The amounts of C3a generated and histamine released directly correlated with the extent of C3 consumption. Furthermore, when C3a and C5a inactivation by serum carboxypeptidase N was prevented by DL-2-mercapto-methyl-3-guanidino-ethylthiopropanoic acid, anaphylactic histamine release was enhanced, and chronotropic and inotropic responses were potentiated and prolonged. Notably, the administration of C3a to nonsensitized guinea pig atria and papillary muscles caused positive chronotropic and inotropic effects, which were associated with histamine release and were antagonized by the H2 receptor blocker cimetidine, thereby mimicking the effects of anaphylaxis. Our findings indicate that complement activation and anaphylatoxin generation are typical of cardiac anaphylaxis and suggest that anaphylatoxins function as mediator-modulators of immediate hypersensitivity reactions of the heart.
Similar articles
-
Cardiac anaphylaxis. Complement activation as an amplification system.Circ Res. 1989 Sep;65(3):847-57. doi: 10.1161/01.res.65.3.847. Circ Res. 1989. PMID: 2475275
-
Pulmonary injury induced by C3a and C5a anaphylatoxins.Am J Pathol. 1980 Aug;100(2):327-48. Am J Pathol. 1980. PMID: 6967702 Free PMC article.
-
Dissociation of cimetidine effects on inotropic and chronotropic action in cardiac anaphylaxis.Zhongguo Yao Li Xue Bao. 1989 Mar;10(2):140-3. Zhongguo Yao Li Xue Bao. 1989. PMID: 2816414
-
Cardiac anaphylaxis: the role of different mediators. Part I: Histamine.Allergol Immunopathol (Madr). 1985 May-Jun;13(3):259-72. Allergol Immunopathol (Madr). 1985. PMID: 2412425 Review.
-
Immunopharmacology of anaphylatoxin-induced bronchoconstrictor responses.Complement. 1986;3(3):137-51. doi: 10.1159/000467891. Complement. 1986. PMID: 3026723 Review.
Cited by
-
Therapeutic controversies in the management of acute anaphylaxis.J Accid Emerg Med. 1998 Mar;15(2):89-95. doi: 10.1136/emj.15.2.89. J Accid Emerg Med. 1998. PMID: 9570047 Free PMC article. Review. No abstract available.
-
Trichosanthin, an initiator of the alternative complement activation pathway.Clin Exp Immunol. 1993 Aug;93(2):248-52. doi: 10.1111/j.1365-2249.1993.tb07974.x. Clin Exp Immunol. 1993. PMID: 8348752 Free PMC article.
-
Human heart as a shock organ in anaphylaxis.Allergo J Int. 2014;23(2):60-66. doi: 10.1007/s40629-014-0007-3. Epub 2014 Mar 19. Allergo J Int. 2014. PMID: 26120516 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Miscellaneous